Fulcrum Therapeutics, Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 76.94. In total, the insiders bought 11 492 598 and sold 6 304 443 FULC shares in the last 100 trades.

Insider Power

(Last 100 transactions)
76.94
Buy 11 492 598 Shares
Sell 6 304 443 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 17, 2024 Stock Option (right to buy) Buy Ezekowitz Alan 30 000
Jun 17, 2024 Stock Option (right to buy) Buy Gould Robert J 30 000
Jun 17, 2024 Stock Option (right to buy) Buy Haviland Kate 30 000
Jun 17, 2024 Stock Option (right to buy) Buy Geraghty James A 30 000
Jun 17, 2024 Stock Option (right to buy) Buy Dorton Katina 30 000
Jun 17, 2024 Stock Option (right to buy) Buy Collins James J. 30 000
Jun 17, 2024 Stock Option (right to buy) Buy Banks Sonja 30 000
Jun 17, 2024 Stock Option (right to buy) Buy Hill Colin 60 000
Jun 17, 2024 No securities are beneficially owned Buy Hill Colin 0
May 07, 2024 Common Stock Sell Tourangeau Greg 236
Mar 18, 2024 Stock Option (right to buy) Buy Horn Patrick Taylor 400 000
Mar 18, 2024 No securities are beneficially owned Buy Horn Patrick Taylor 0
Mar 08, 2024 Common Stock Sell Tourangeau Greg 4 884
Mar 04, 2024 Common Stock Buy Sapir Alex 43 360
Jan 26, 2024 Stock Option (right to buy) Buy Tourangeau Greg 83 820
Jan 26, 2024 Stock Option (right to buy) Buy Tourangeau Greg 10 000
Jan 26, 2024 Stock Option (right to buy) Buy Musso Alan A 100 000
Jan 26, 2024 Stock Option (right to buy) Buy Oltmans Curtis Gale 150 000
Jan 17, 2024 Stock Option (right to buy) Buy Musso Alan A 61 822
Aug 07, 2023 Stock Option (right to buy) Buy Musso Alan A 432 800
Aug 07, 2023 No securities are beneficially owned Buy Musso Alan A 0
Jul 01, 2023 Stock Option (right to buy) Buy Sapir Alex 2 430 400
Jun 27, 2023 Stock Option (right to buy) Buy Geraghty James A 30 000
Jun 27, 2023 Stock Option (right to buy) Buy Haviland Kate 30 000
Jun 27, 2023 Stock Option (Right to Buy) Buy Dorton Katina 30 000
Click to get the best stock tips daily for free!

About Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics. Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin inducer for the treatment of sickle cell di... FULC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT